Omega Therapeutics (OMGA) Stock Forecast & Price Target

→ Must-See: Elon’s New Invention is Absolutely Insane (From InvestorPlace) (Ad)

$2.22

+0.36 (+19.35%)

(As of 06/18/2024 ET)

Omega Therapeutics - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Buy
Based on 5 Analyst Ratings

Consensus Price Target

$10.40
368.47% Upside

High Forecast	$12.00
Average Forecast	$10.40
Low Forecast	$7.00

Type	Current Forecast 6/20/23 to 6/19/24	1 Month Ago 5/21/23 to 5/20/24	3 Months Ago 3/22/23 to 3/21/24	1 Year Ago 6/20/22 to 6/20/23
Consensus Rating	Buy	Buy	Buy	Buy
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	5 Buy rating(s)	4 Buy rating(s)	3 Buy rating(s)	4 Buy rating(s)
Hold	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)	0 Hold rating(s)
Sell	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$10.40	$10.00	$12.00	$11.00
Forecasted Upside	368.47% Upside	325.53% Upside	190.79% Upside	74.40% Upside

Get Omega Therapeutics Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for OMGA and its competitors with MarketBeat's FREE daily newsletter.

Ad InvestorPlace

Must-See: Elon’s New Invention is Absolutely Insane

Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street veteran, Eric Fry… This mind-blowing new technology could be bigger than the iPhone.

Click here for the full story…

OMGA Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

OMGA Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Omega Therapeutics Stock vs. The Competition

Type	Omega Therapeutics	Medical Companies	S&P 500
Consensus Rating Score	3.00	2.70	2.50
Consensus Rating	Buy	Moderate Buy	Hold
Predicted Upside	368.47% Upside	1,068.17% Upside	11.30% Upside
News Sentiment Rating	Very Positive News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Action	Rating	Price Target	Upside/Downside on Report Date
6/18/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$12.00	+545.16%
5/13/2024	HC Wainwright Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$12.00	+512.24%
5/7/2024	Chardan Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy	$7.00 ➝ $7.00	+209.73%
5/6/2024	Wedbush Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Outperform	$12.00	+426.31%
4/3/2024	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$10.00 ➝ $9.00	+210.34%
3/10/2023	Jonestrading Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy	$11.00	+75.72%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:09 AM ET.

OMGA Forecast - Frequently Asked Questions

What is Omega Therapeutics's stock forecast and purchase recommendation?: According to the research reports of 5 Wall Street equities research analysts, the average twelve-month stock price forecast for Omega Therapeutics is $10.40, with a high forecast of $12.00 and a low forecast of $7.00. The consensus rating for Omega Therapeutics stock is Buy based on the current 5 buy ratings for OMGA. Learn more on OMGA's analyst rating history.
Do Wall Street analysts like Omega Therapeutics more than its competitors?: Analysts like Omega Therapeutics more than other "medical" companies. The consensus rating for Omega Therapeutics is Buy while the average consensus rating for "medical" companies is Moderate Buy. Learn more on how OMGA compares to other companies.
Does Omega Therapeutics's stock price have much upside?: According to analysts, Omega Therapeutics's stock has a predicted upside of 361.81% based on their 12-month stock forecasts.

What analysts cover Omega Therapeutics?: Omega Therapeutics has been rated by research analysts at Chardan Capital, HC Wainwright, Piper Sandler, Raymond James, and Wedbush in the past 90 days.